News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires4d agoneutral
UBS Adjusts Pfizer Price Target to $30 From $27, Maintains Neutral RatingMT Newswires4d agoneutral
RBC Raises Price Target on Pfizer to $28 From $25, Keeps Sector Perform Rating24/7 Wall St.76d agoneutral
Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price Target24/7 Wall St.80d agoneutral
Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead